|
|
|
Volumn 36, Issue 2, 2011, Pages 102-
|
|
American Society of Hematology, 52nd Annual Meeting and Exposition: Lenalidomide (Revlimid) maintenance therapy for multiple myeloma after transplantation: The IFM 2005-02 trial, final analysis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LENALIDOMIDE;
PLACEBO;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CONFERENCE PAPER;
DEEP VEIN THROMBOSIS;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FOLLOW UP;
HUMAN;
MAINTENANCE THERAPY;
MULTIPLE MYELOMA;
NEUTROPENIA;
OVERALL SURVIVAL;
PERIPHERAL NEUROPATHY;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
|
|
EID: 79952205460
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
